Hu Yugang, Zhou Jia, Cao Quan, Wang Hao, Yang Yuanting, Xiong Ye, Zhou Qing
Department of Ultrasound Imaging, Renmin Hospital of Wuhan University, Wuhan, 430061, People's Republic of China.
Int J Gen Med. 2021 Jun 1;14:2205-2213. doi: 10.2147/IJGM.S310445. eCollection 2021.
We aimed to investigate the association between usage of transthoracic echocardiography (TTE) within 24 hours after acute kidney injury (AKI) and the prognosis of patients in intensive care unit (ICU).
The Medical Information Mart for Intensive Care III (MIMIC-III) database was used to identify AKI patients with and without TTE administration. The primary outcome was 28-day mortality. Multivariable regression was used to clarify the association between TTE and clinical outcomes and propensity score matching (PSM) and inverse probability of treatment weighting (IPTW) were utilized to validate our findings.
Among 23,945 eligible AKI patients, 3361 patients who received TTE and 3361 who did not conduct TTE had similar propensity scores which were included in this study. After matching, the TTE group had a significantly lower 28-day mortality (OR 0.80, 95% CI 0.72-0.88, P<0.001). Patients in the TTE group received more fluid on day 1 and day 2 and had a more urine volume on day 1 and day 3, and the reduction in serum creatinine was greater than that in the no TTE group. The mediating effect of creatinine reduction was remarkable for the whole cohort (P=0.02 for the average causal mediation effect).
TTE utilization was associated with decreased risk-adjusted 28-day mortality for AKI patients in ICU and was proportionally mediated through creatinine reduction.
我们旨在研究急性肾损伤(AKI)后24小时内经胸超声心动图(TTE)的使用与重症监护病房(ICU)患者预后之间的关联。
使用重症监护医学信息集市三期(MIMIC-III)数据库来识别接受和未接受TTE检查的AKI患者。主要结局是28天死亡率。采用多变量回归来阐明TTE与临床结局之间的关联,并利用倾向评分匹配(PSM)和治疗权重逆概率(IPTW)来验证我们的研究结果。
在23945例符合条件的AKI患者中,3361例接受TTE检查的患者和3361例未接受TTE检查的患者具有相似的倾向评分,被纳入本研究。匹配后,TTE组的28天死亡率显著降低(OR 0.80,95%CI 0.72-0.88,P<0.001)。TTE组患者在第1天和第2天接受了更多的液体输入,在第1天和第3天尿量更多,血清肌酐的下降幅度大于未接受TTE检查的组。肌酐降低的中介作用在整个队列中显著(平均因果中介效应P=0.02)。
TTE的使用与ICU中AKI患者经风险调整后的28天死亡率降低相关,且通过肌酐降低成比例地介导。